New York City, NY -- (SBWIRE) -- 10/03/2013 -- StockMarketIntel.com issues a special report on the following stocks: Federal National Mortgage Association(OTCBB:FNMA), 22nd Century Group Inc(OTCBB:XXII), Unseen Solar, Inc.(OTCMKTS:PCWT), Cellceutix Corp(OTCMKTS:CTIX)
Federal National Mortgage Association(OTCBB:FNMA) reported the gain of 11.59% and closed at $1.54 with the total traded volume of 42.59 million shares. Its market capitalization is $ 2.64 billion. The stock has a 52-week high price of $0.25 and its 52-week low was recorded at $5.44
Federal National Mortgage Association Fannie Mae is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage-related assets are purchased and sold.
What FNMA Charts Are Signaling for Traders? Find Out Here
22nd Century Group Inc(OTCBB:XXII) gain 4.62% and ended at $1.36.The total traded volume was 1.59M shares and market capitalization arrived at $65.39 million. The stock has a 52-week high price of $1.74 and its 52-week low was recorded at $0.15, while during last trade its minimum price was $1.26 and it gained the highest price of $1.70.
22nd Century Group, Inc. (22nd Century Group) is a holding company. The Company’s wholly owned subsidiary, 22nd Century Limited, LLC (22nd Century Ltd), which is a plant biotechnology company. The Company’s products include X-22 Smoking Cessation Aid, Modified Risk Cigarettes, BRAND A Cigarettes and BRAND B Cigarettes.
Is XXII Buy After The Recent Price Movement? Find Out Here
Unseen Solar, Inc.(OTCMKTS:PCWT)’s reported gain 2.29% and close at $0.223 with the overall traded volume of 3.10m shares. Its market capitalization on last close reached to $196.20 million. Its intraday-low price was $0.22 and its hit its day's highest price at $0.23.
Should PCWT a Buy or Sell Now? Find Out Here
Cellceutix Corp(OTCMKTS:CTIX) increase 3.39% settle at $1.83. Its total traded volume during last trading session was 336.92K shares. The overall market worth of this company is about $178.18 million. The 52 week range of the stock remained $0.774 - $2.47, while its day's lowest price was $1.78 and its hit its day's highest price at $1.85.
Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.
What CTIX Charts Are Signaling for Traders? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)